Cuorips Inc. (JP:4894)

:4894

4894

Cuorips Inc.

RESEARCH TOOLSreports

Want to see JP:4894 full AI Analyst Report?

Cuorips Inc. (4894) Price & Analysis

1 Followers

4894 Stock Chart & Stats

¥6230.00

¥25.00(0.51%)

At close: Jan 08 4:00 PM EST

¥6230.00

¥25.00(0.51%)

Day’s Range― - ―

52-Week Range¥5,580.00 - ¥12,400.00

Previous CloseN/A

Volume173.60K

Average Volume (3M)107.56K

Market Cap

¥55.00B

Enterprise Value¥52.10B

Total Cash (Recent Filing)¥4.85B

Total Debt (Recent Filing)¥0.00

Price to Earnings (P/E)―

Beta1.10

Next Earnings

May 20, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-30.15

Shares Outstanding8,273,376

10 Day Avg. Volume98,200

30 Day Avg. Volume107,556

Financial Highlights & Ratios

PEG Ratio16.56

Price to Book (P/B)12.03

Price to Sales (P/S)379.55

P/FCF Ratio-74.48

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Revenue AccelerationA 404% YoY revenue increase demonstrates meaningful commercial traction and accelerating product adoption from a small base. Over a multi-month horizon this durable trend supports scalable revenue potential, improving the odds that fixed R&D and SG&A can be absorbed as sales grow.

Debt-free Balance SheetNo reported debt and a sizable equity cushion materially reduce refinancing and interest-rate risk, providing financial flexibility. This structural strength gives the company runway to fund ongoing development and commercialization without immediate leverage-related constraints.

Positive Gross ProfitPositive gross profit indicates product-level economics are viable and that revenues cover direct costs. Over a 2–6 month horizon this suggests the company can improve margins with scale, a durable prerequisite for reaching operating break-even if fixed costs are managed.

Bears Say

Large Operating Losses & Cash BurnPersistently negative operating and free cash flow shows the business consumes substantial cash to run operations and pursue R&D. This structural cash burn raises dilution and financing risk over months, forcing dependence on external funding unless losses are reduced or new capital is secured.

Negative Returns On EquityOngoing negative ROE means shareholder capital is being eroded rather than generating returns, a durable sign of operational underperformance. Without sustained profitability improvements, equity value may decline and management may need dilutive or transformative actions to restore returns.

Far From Operating Break-evenDeep and persistent operating losses indicate the company remains structurally unprofitable despite revenue growth. Over the medium term, unless revenue growth significantly outpaces cost growth or margins improve, the firm's strategic plans and runway will be constrained by profitability shortfalls.

4894 FAQ

What was Cuorips Inc.’s price range in the past 12 months?

Cuorips Inc. lowest stock price was ¥5580.00 and its highest was ¥12400.00 in the past 12 months.

What is Cuorips Inc.’s market cap?

Cuorips Inc.’s market cap is ¥55.00B.

When is Cuorips Inc.’s upcoming earnings report date?

Cuorips Inc.’s upcoming earnings report date is May 20, 2026 which is in 18 days.

How were Cuorips Inc.’s earnings last quarter?

Cuorips Inc. released its earnings results on Feb 18, 2026. The company reported -¥30.15 earnings per share for the quarter, missing the consensus estimate of N/A by -¥30.15.

Is Cuorips Inc. overvalued?

According to Wall Street analysts Cuorips Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Cuorips Inc. pay dividends?

Cuorips Inc. does not currently pay dividends.

What is Cuorips Inc.’s EPS estimate?

Cuorips Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Cuorips Inc. have?

Cuorips Inc. has 8,273,376 shares outstanding.

What happened to Cuorips Inc.’s price movement after its last earnings report?

Cuorips Inc. reported an EPS of -¥30.15 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 5.324%.

Which hedge fund is a major shareholder of Cuorips Inc.?

Currently, no hedge funds are holding shares in JP:4894

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Cuorips Inc.

Cuorips Inc. engages in the research, development, manufacture, commercialization, and sale of iPS cell-derived cardiomyocyte sheets. The company offers cellular and tissue-based, and cell processing products. It also provides contract development and manufacturing, and consulting services. The company was formerly known as Cuore Inc. and changed its name to Cuorips Inc. in June 2017. Cuorips Inc. was incorporated in 2017 and is headquartered in Tokyo, Japan.